Free Weekly Newsletter.
We've been publishing our newsletter since 1998, and have had our share of huge winners including Immunomedics (IMMU) $3.00 to $86.00 (2016-2020). So sign up, it's free, and see what else we can come up with!
ALL NEWS
TMC Pushes US Seafloor Mining Hub.
With 413 million shares outstanding, TMC has lost $2.9 billion in market value in the most recent rout!
Investors have to keep reminding themselves that a pre-feasibility study issued earlier this year assigned a net...
Palantir’s Billionaire CEO, “People With ADHD Will Succeed in the AI Era.”
“There are basically two ways to know you have a future,” the 58-year-old billionaire Alex Karp said on TBPN earlier this month. “One, you have some vocational training. Or two, you’re neurodivergent.” More broadly, neurodivergence can include conditions such...
Trader in Iran Made Nearly $1 Million on Polymarket With Remarkably Accurate War Bets!
This is fun reading..from CNN
Full Article on CNN
Institutional Gold Analyst: 2026 Precious Metals Watch List.
The Perfect Timing - for Precious Metals..
Timing is a 'personal' issue, related to short and long-term investor goals, but generally speaking (for long-term investors), the timing right now to build a precious metals model...
The Iran War and AI Cyber Threats
Virtually all cyberattacks will be AI-enabled or entirely AI, says Armadin CEO Kevin Mandia
Kevin Mandia, Armadin CEO, joins ‘Squawk Box’ to discuss the cyber threats facing the U.S. amid the Iran war, impact of...
National Investment Bankers Conference Cheat Sheet
Companies Scheduled to Present
Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. They have hosted 150 investment conferences showcasing public and private companies seeking access to...
Report: Sekur Private Data (SWISF) Awarded Place on GSA Schedule.
This Week's GSA Announcement Marks Sekur’s 4th Major Milestone.
GSA Approval is akin to an electrician just starting out in the business, and being told by a friend "I know a guy, my cousin, who...
Sekur Private Data (SWISF) Locked and Loaded.
We Can Feel the Wind Behind Its Back!
Sekur (SWISF) probably has one of the simplest stories we follow. Risky because it is a modestly financed start-up. Today they announced a progress report for shareholders...
Gold, Silver & Critical Minerals Update.
Like with Most in Precious Metals, Our Ideas are Performing Rather Well.
And we have a new name! Adding Americore Resources (AMCOF) $0.54, to the 2026 Watch List.
We got bullish on Gold back...
News Update on Society Pass (SOPA) $0.64.
Society Pass (SOPA) $0.64, Announces $3.0 Million Public Offering; Share Count Increases to Approximately 13.0 Million.
Review of four Research Reports with Price Targets Exceeding $10 Per Share
Click to review the report.
Society Pass Incorporated (“Society...
Latest Research Report: $20 Price Target from Greenridge Global.
Here are four research reports below to peruse, all with price targets $20.00 or more...
While we don't issue price targets, it's comforting to see each of these 'sum of the parts' analyst reports. While...
Three More Companies Suspended by SEC!
Millions of Investor's Dollars are Being Trapped.
These three companies had a combined market cap of $563 million at the time they were halted, whose shares can't be sold! Brings new meaning to the term...
The Y-Combinator Incubator | Top 10 Performing Portfolio Holdings
Y Combinator, LLC (YC) is an US based technology startup accelerator and venture capital firm launched in March 2005, that has incredibly - been used to launch more than 5,000 start-ups. The accelerator program started...
Society Pass (SOPA) Perking Up, Gains 169% in Last Trading Five Days.
For the record, we are not traders. And that 'not-something-moniker' dates back to 1995. So while it's nice to see it perking up, we have been following Society Pass for quite sometime now, and...
GeoVax (GOVX) $0.15 And Nope, We Are Not Panicking!
Full Report Monday!
And we're not letting this spoil our Christmas..
LIVE QUOTE
But yes, it sucks, and yes, we've been here before. And no, we were not originally intending on spending our entire pre-holiday weekend, writing...
The Iran War and AI Cyber Threats
Virtually all cyberattacks will be AI-enabled or entirely AI, says Armadin CEO Kevin Mandia
Kevin Mandia, Armadin CEO, joins ‘Squawk Box’ to discuss the cyber threats facing the U.S. amid the Iran war, impact of...
Sekur Private Data (SWISF) Locked and Loaded.
We Can Feel the Wind Behind Its Back!
Sekur (SWISF) probably has one of the simplest stories we follow. Risky because it is a modestly financed start-up. Today they announced a progress report for shareholders...
News Update on Society Pass (SOPA) $0.64.
Society Pass (SOPA) $0.64, Announces $3.0 Million Public Offering; Share Count Increases to Approximately 13.0 Million.
Review of four Research Reports with Price Targets Exceeding $10 Per Share
Click to review the report.
Society Pass Incorporated (“Society...
Latest Research Report: $20 Price Target from Greenridge Global.
Here are four research reports below to peruse, all with price targets $20.00 or more...
While we don't issue price targets, it's comforting to see each of these 'sum of the parts' analyst reports. While...
AI Data Center Short – Jim Chanos
“If the economic life on these things is three years ... the whole economics of a lot of these deals kind of falls apart."
Nvidia’s (NVDA) AI chips have fueled a new debt market,...
GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...
Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
BioPharm
David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States.
Editor's Note: The views an opinions expressed...
Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
Adding Oncolytics Biotech Inc. (ONCY) $1.02 to 2025 Watch List.
The Oncolytics Biotech Inc. (ONCY) idea is coming from one of our top 'tipsters' the Big Wig - whose two previous ideas, Allarity (ALLR)...
We’re Up 118% on Allarity (ALLR) Today.
Since adding Allarity (ALLR) to the Watch List at $0.70, we are up 194%, and that ain't bad - for exactly 4 months and...
IPOS
Snowflake (SNOW) vs Facebook (FB) IPO.
Better to Wait a Year?
Snowflake shares more than double. It's the biggest software IPO ever
Price at $120, opening looks like $280. What the?
We remember...
conference calls
Travel Technology: Marriott to Open 1,700 Hotels in Three Years. Conference...
Marriott Bonvoy Reached 125 Million Members.
Marriott International Announces Three-Year Growth Plan
Growth Model Shows $9.5 to $11 Billion Could be Returned to Shareholders
BETHESDA, Md., March...
Most popular
Is Citius Pharma a Ten Bagger?
As is From $0.80 to $8.00..
One of our favorite Broker/Dealer Analysts thinks it is..
Positive news today from an old favorite Citius Pharma (CTXR),...
Our Favorite Incubator, Incubates! Telehealth in its Future?
True Nature|Mitesco has found an excellent first Company to incubate and help grow, called MyCare.The founders of the Minute Clinic are teaming up again...
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we follow, shows a spike in either...
Atai Life Sciences (ATAI) Founder Christian Angermayer Interview.(VIDEO)
Best Psychedelic related interview we've seen yet. Christian states, "I think ultimately, the total addressable market is 100% of the world population!"
Wait, what? Is he suggesting...















































